Product Images Spironolactone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Spironolactone NDC 72603-135 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure - spironolactone fig1
This appears to be a table or graph showing data on the use of Spironolactone compared to a placebo in a study involving 822 participants who received Spironolactone and 841 participants who received a placebo. The data is related to probability and includes a log-rank p-value of < 0001. The numbers 02, 01, 00, B, and T 2 are also included, but their significance is unclear without additional context. The timeframe for the study appears to be 18-24 months.*
fig2 - spironolactone fig2
This appears to be a table with various parameters such as age, race, heart failure, diabetes, kidney function, potassium level, medications (such as digoxin, beta blockers, and spironolactone), and HR (heart rate) and 95% CI (confidence interval) values. The table seems to be comparing spironolactone and placebo in terms of efficacy.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (100 Tablets Bottle) - spironolactone fig3
Each tablet of this medicine contains 25 mg of Spironolactone USP and is manufactured by Aurobindo Pharma Limited. The medicine comes in a container that is child-resistant and light-resistant. The usual dosage information is provided in the accompanying prescribing information. The medicine is sold in a pack containing 100 tablets. The manufacturing company is Northstar Rx LLC based in Memphis, TN 38141. The given NDG number is 72603-134-01, and the M.LNo. is 19/HD/AP/95/F/R, dated 03/2023.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (100 Tablets Bottle) - spironolactone fig4
Each tablet contains 50 mg of Spironolactone USP manufactured by Northstar Rx LLC in Memphis, TN. The usual dosage is provided in the accompanying prescribing information. The tablets are dispensed in child-resistant containers and should be stored at 20° to 25°C. The manufacturer is Aurobindo Pharma Limited in Hyderabad, India. The lot number is 19/HD/AP/95/F/R and the expiration date is March 2023. No information is available about the overprinting zone and goding area.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (100 Tablets Bottle) - spironolactone fig5
NDC 72603-136-01 is a medication containing Spironolactone in the form of tablets. Each tablet contains 100 mg of Spironolactone USP, and the recommended dosage can be found in the accompanying prescribing information. The tablets should be dispensed in tight and child-resistant containers and stored in a place protected from light at a temperature between 20° to 25°C (68° to 77°F). This product is manufactured for Northstar Rx LLC by Aurobindo Pharma Limited in Hyderabad-500 090, India. The text includes identifiers, dosage information, storage instructions, and the manufacturing information of the medication.*
str1 - spironolactone str1
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.